Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study (Q35836302)
Jump to navigation
Jump to search
scientific article published on May 1, 1992
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study |
scientific article published on May 1, 1992 |
Statements
Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study (English)
1 reference
Shands JW Jr
1 reference
R. Ramphal
M. Bolger
D. J. Oblon
R. J. Sherertz
J. D. Malone
K. H. Rand
M. Gilliom
J. W. Shands
1 reference
1 reference
Identifiers
1 reference